Key statistics
As of last trade IMCD NV (INX:STU) traded at 136.05, 7.85% above its 52-week low of 126.15, set on Jul 12, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 138.10 |
---|---|
High | 138.10 |
Low | 135.50 |
Bid | 137.20 |
Offer | 138.50 |
Previous close | 137.05 |
Average volume | 0.00 |
---|---|
Shares outstanding | 59.11m |
Free float | 58.11m |
P/E (TTM) | 27.84 |
Market cap | 8.12bn EUR |
EPS (TTM) | 4.93 EUR |
Annual div (ADY) | 2.24 EUR |
---|---|
Annual div yield (ADY) | 1.65% |
Div ex-date | May 16 2024 |
Div pay-date | May 21 2024 |
Data delayed at least 15 minutes, as of Nov 21 2024.
More ▼
Announcements
- IMCD N.V. successfully raises EUR 300 million through an accelerated bookbuild offering of new shares
- IMCD N.V. LAUNCHES A CAPITAL RAISE OF EUR 300 MILLION TO INCREASE FINANCIAL FLEXIBILITY
- IMCD reports EBITA of EUR 403 million in the first nine months of 2024
- IMCD acquires Blumos Group to accelerate its growth in the life science markets in Latin America
- IMCD successfully issues a EUR 500 million rated bond
- IMCD reports EBITA of EUR 270 million in the first half of 2024
- IMCD Italy expands its Pharmaceuticals presence with the acquisition of Selechimica
- Shareholders IMCD N.V. adopt all resolutions at AGM
- IMCD reports EBITA of EUR 127 million in the first three months of 2024
- IMCD Spain expands its Pharmaceuticals presence with the acquisition of Cobapharma
More ▼